Plantar Fasciitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2027

This research gauges the historical as well as current scenario of the global plantar fasciitis treatment market, to accurately evaluate its future opportunistic development. The report includes comprehensive information about the vital growth influencers, trends, and restraints that are impacting the growth of the plantar fasciitis treatment market, to spot the lucrativeness of the business potential for market players. The report also provides detailed information regarding how the plantar fasciitis treatment market will accelerate and underpin momentum during the foreseeable period (2019-2027).

The report offers incisive dynamics about the various aspects and nuances of the plantar fasciitis treatment market, to assist market players in making winning strategies. this report also offers information about the vital changes that are anticipated to shape the plantar fasciitis treatment market during the projection period. It covers a key indicator assessment to underline the range of the growth prospects of the plantar fasciitis treatment market and projection statistics related to the market growth in terms of value (US$ Mn).

The report covers an exhaustive taxonomy of the plantar fasciitis treatment market and riveting insights on the competitive landscape. The report exhibits company profiles of the stakeholders that are vying to grow in the plantar fasciitis treatment market, wherein, a range of development and winning strategies adopted and leveraged by established players as well as market entrants have been presented in a comprehensive manner.

Key Questions Answered in this report on the Plantar Fasciitis Treatment Market

The report offers in-depth information about the plantar fasciitis treatment market, based on detailed research pertaining to the macro and microeconomic determinants that are playing a vital role in influencing the growth potential of the market. Information given in the report answers salient questions for present market players as well as the ones eying entry into the plantar fasciitis treatment market, to help them formulate smart strategies and take business-driving decisions.

Which type of plantar fasciitis treatment will promise the highest gains for the market in 2022?
How are market goliaths successfully cashing in on the growing cases of plantar fasciitis?
What are the winning strategies of market frontrunners in the plantar fasciitis treatment market?
Which end user witnessed the highest traction for plantar fasciitis treatment in 2018?
What rate of ROI can plantar fasciitis treatment market players expect from its oral treatment in the next couple of years?
What will be the Y-o-Y growth of the plantar fasciitis treatment market between 2019 and 2024?

Research Methodology – Plantar Fasciitis Treatment Market

The research methodology leveraged by the analysts for developing the plantar fasciitis treatment market report depends on exhaustive primary as well as secondary research. By delving deep into the industry-validated information that is obtained by relevant sources, analysts have mentioned incisive insights and accurate forecasts of the plantar fasciitis treatment market.

At part of the primary research, analysts conducted interviews with relevant stakeholders in order to gather information about key project objectives. During the secondary research phase, analysts gauged company annual reports and investor presentations. They also obtained data from the websites and press releases of leading market players.

Analysts also considered reports/articles carried by credible sources, including the American Podiatric Medical Association (APMA), National Podiatry Association (NPA), NCBI, Podiatry Today, National Regulatory Authorities such as U.S. FDA, European Medicines Agency, etc., to obtain necessary understanding of the plantar fasciitis treatment market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology3. Executive Summary: Global Plantar Fasciitis Treatment Market

4. Market Overview

4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Plantar Fasciitis Treatment Market Analysis and Forecast, 2017-2027

5. Market Outlook

5.1. Porter’s Five Force Analysis
5.2. Industry Evolution/Developments
5.3. Drug Pipeline for Plantar Fasciitis Treatment
5.4. Technological Advancements in Foot Orthotics/Prosthetics Industry
5.5. Price Comparison Analysis, by Product
5.6. Regulatory Scenario by Region
5.7. Compare FDM, SLA, and SLS Technologies
5.8. Obesity Rates (%) of Total Adult Population

6. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2027
6.3.1. Medication Therapy
6.3.1.1. Oral
6.3.1.2. Parenteral
6.3.2. Orthotics
6.3.3. Shockwave Therapy
6.3.3.1. Extracorporeal Shock Wave Therapy (ESWT)
6.3.3.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
6.3.4. Surgery
6.3.5. Others
6.4. Market Attractiveness, by Type

7. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End User

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End User, 2017-2027
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Others
7.4. Market Attractiveness, by End User

8. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region

8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region

9. North America Plantar Fasciitis Treatment Market Analysis and Forecast

9.1. Introduction
9.2. Market Value Forecast, by Type, 2017-2027
9.2.1. Medication Therapy
9.2.1.1. Oral
9.2.1.2. Parenteral
9.2.2. Orthotics
9.2.3. Shockwave Therapy
9.2.3.1. Extracorporeal Shock Wave Therapy (ESWT)
9.2.3.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
9.2.4. Surgery
9.2.5. Others
9.3. Market Value Forecast, by End User, 2017-2027
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2027
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By End User
9.5.3. By Country

10. Europe Plantar Fasciitis Treatment Market Analysis and Forecast

10.1. Introduction
10.2. Market Value Forecast, by Type, 2017-2027
10.2.1. Medication Therapy
10.2.1.1. Oral
10.2.1.2. Parenteral
10.2.2. Orthotics
10.2.3. Shockwave Therapy
10.2.3.1. Extracorporeal Shock Wave Therapy (ESWT)
10.2.3.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
10.2.4. Surgery
10.2.5. Others
10.3. Market Value Forecast, by End User, 2017-2027
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2027
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By End User
10.5.3. By Country/Sub-region

11. Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast

11.1. Introduction
11.2. Market Value Forecast, by Type, 2017-2027
11.2.1. Medication Therapy
11.2.1.1. Oral
11.2.1.2. Parenteral
11.2.2. Orthotics
11.2.3. Shockwave Therapy
11.2.3.1. Extracorporeal Shock Wave Therapy (ESWT)
11.2.3.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
11.2.4. Surgery
11.2.5. Others
11.3. Market Value Forecast, by End User, 2017-2027
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2027
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By End User
11.5.3. By Country/Sub-region

12. Latin America Plantar Fasciitis Treatment Market Analysis and Forecast

12.1. Introduction
12.2. Market Value Forecast, by Type, 2017-2027
12.2.1. Medication Therapy
12.2.1.1. Oral
12.2.1.2. Parenteral
12.2.2. Orthotics
12.2.3. Shockwave Therapy
12.2.3.1. Extracorporeal Shock Wave Therapy (ESWT)
12.2.3.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
12.2.4. Surgery
12.2.5. Others
12.3. Market Value Forecast, by End User, 2017-2027
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By End User
12.5.3. By Country/Sub-region

13. Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast

13.1. Introduction
13.2. Market Value Forecast, by Type, 2017-2027
13.2.1. Medication Therapy
13.2.1.1. Oral
13.2.1.2. Parenteral
13.2.2. Orthotics
13.2.3. Shockwave Therapy
13.2.3.1. Extracorporeal Shock Wave Therapy (ESWT)
13.2.3.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
13.2.4. Surgery
13.2.5. Others
13.3. Market Value Forecast, by End User, 2017-2027
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By End User
13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Share Analysis, by Company, 2018
14.2. Market Player - Competition Matrix (By Tier and Size of companies)
14.3. Company Profiles
14.3.1. Hanger, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Bayer Group (Dr. Scholl's)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. A. Algeo Limited
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. SWOT Analysis
14.3.3.3. Strategic Overview
14.3.4. Bauerfeind AG
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. SWOT Analysis
14.3.4.3. Strategic Overview
14.3.5. Superfeet Worldwide, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. SWOT Analysis
14.3.5.3. Strategic Overview
14.3.6. Ottobock SE & Co. KGaA (Ottobock Holding)
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. SWOT Analysis
14.3.6.3. Strategic Overview
14.3.7. Pfizer, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Sanofi
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. GlaxoSmithKline plc
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview